Author: Jonathan Banks

TB006 for Dementia Now Available Through Expanded Access

A New Avenue of Hope for Dementia Patients Dementia, including Alzheimer’s disease, continues to affect millions of individuals and families, often progressing despite currently approved treatments. While breakthroughs in research have been limited, a new investigational drug—TB006—offers renewed hope. This treatment, developed by TrueBinding, has shown early signs of reversing cognitive symptoms in clinical trials. […]